Literature DB >> 25497384

pERK1/2 immunofluorescence in rat dorsal horn and paraventricular nucleus neurons as a marker for sensitization and inhibition in the pain pathway.

J Donnerer1, I Liebmann2.   

Abstract

The aim of the present study was to investigate whether the phosphorylation of ERK1/2 in the rat lumbar dorsal horn and in the parvocellularis part of the paraventricular nucleus can be used to visualize neuronal activity. pERK1/2 fluorescence-immunohistochemistry is specifically suited to mirror neuronal activity in the pain pathway following an acute noxious stimulation. The rat hind paw was either stimulated by noxious heat or by a sequence of mustard oil and noxious heat. Two and 10 min after the thermal stimulation a 3-4-fold increase in cells with pERK1/2 immunoreactivity was observed in lamina I/II of the L3-L5 dorsal horn. The combination of mustard oil with heat led to a 5-6-fold increase in the pERK1/2 signal. The pERK1/2 immunoreactivity in the parvocellularis part of the paraventricular nucleus increased by 2-fold following the heat stimulus, with no further increase following the sequential mustard oil and heat stimulus. A pretreatment with the opioid analgesic morphine or the NMDA antagonist MK-801 markedly attenuated ERK1/2 phosphorylation in both areas of the pain pathway. The present findings support the concept that the pERK1/2 immunofluorescence signal can be used as a quantitative marker for sensitization or inhibition in the pain pathway at spinal and hypothalamic level.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ERK1/2 phosphorylation; Hypothalamus; NMDA antagonist; Nociception; Opioid analgesic; Spinal cord

Mesh:

Substances:

Year:  2014        PMID: 25497384     DOI: 10.1016/j.tice.2014.11.003

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  2 in total

Review 1.  Sensitization and Interoception as Key Neurological Concepts in Osteopathy and Other Manual Medicines.

Authors:  Giandomenico D'Alessandro; Francesco Cerritelli; Pietro Cortelli
Journal:  Front Neurosci       Date:  2016-03-10       Impact factor: 4.677

2.  Celecoxib alleviates oxaliplatin-induced hyperalgesia through inhibition of spinal ERK1/2 signaling.

Authors:  Hongping Chen; Qinghua Wang; Danni Shi; Dongbo Yao; Lei Zhang; Junping Xiong; Baohua Xu
Journal:  J Toxicol Pathol       Date:  2016-09-21       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.